Мы используем файлы cookie.
Продолжая использовать сайт, вы даете свое согласие на работу с этими файлами.
Medical treatments
Azficel-T
Другие языки:

    Azficel-T

    Подписчиков: 0, рейтинг: 0

    Azficel-T
    Clinical data
    Trade names Laviv
    AHFS/Drugs.com Micromedex Detailed Consumer Information
    License data
    Routes of
    administration    		 Intradermal
    ATC code
    • None
    Legal status
    Legal status
    Identifiers
    DrugBank
    UNII

    Azficel-T, sold under the brand name Laviv, is a cell therapy product for the improvement of the appearance of moderate to severe nasolabial fold wrinkles in adults. It consists of fibroblasts harvested from the patient's own skin.

    It was approved for medical use in the United States in June 2011.

    Further reading

    • Smith SR, Munavalli G, Weiss R, et al. (July 2012). "A multicenter, double-blind, placebo-controlled trial of autologous fibroblast therapy for the treatment of nasolabial fold wrinkles". Dermatol Surg. 38 (7 Pt 2): 1234–43. doi:10.1111/j.1524-4725.2012.02349.x. PMID 22409385. S2CID 24901992.

    External links

    • "Azficel-T". Drug Information Portal. U.S. National Library of Medicine.
    • "Laviv (azficel-T)". Medscape. 28 September 2019.
    • Clinical trial number NCT02120781 for "Controlled Study to Evaluate the Safety and Efficacy of Azficel-T for the Treatment of Vocal Fold Scarring and Age-Related Dysphonia" at ClinicalTrials.gov



    Новое сообщение